Lamictal, GlaxoSmithKline's brand name drug for the generic medication "lamotrigine," was approved by the FDA in 1997 for treatment of epileptic seizures.  In 2003 the FDA approved Lamictal for bipolar disorder. 

Lamictal does have a very serious side effect that takes the form of an allergy. The medication can cause a very serious skin rash that, in its worst forms, results in death. When Lamictal was first prescribed, about 10% of all patients developed this life-threatening rash, which is a terrible rate of negative reaction. However, doctors soon found that the likelihood of suffering this allergic reaction decreases the longer the medication is in use. By beginning with a very low dosage of Lamictal and progressively increasing the dosage to an effective level, patients can grow acclimated to the drug and in doing so avoid the rash.

Hillyard, Wahlberg, Kudla & Sloane, LLP is actively pursuing claims on behalf of dozens of patients nationwide who were severely injured --families whose loved ones died-- as a result of adverse reaction to Lamictal.  If you or a loved one have suffered a serious adverse reaction to Lamictal and feel that you were not properly warned about the dangers, contact Hillyard, Wahlberg, Kudla & Sloane, LLP today to discuss your options and possibly join in a lawsuit to improve the packaging and warnings about Lamictal's side effects.